BlackRock, Inc. 13D and 13G filings for United Therapeutics Corporation:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2024-01-24 09:46 am Purchase | 2023-12-31 | 13G | United Therapeutics Corporation UTHR | BlackRock Inc. BLK | 5,294,844 11.300% | 567,858 (+12.01%) | Filing |
| 2023-03-08 2:19 pm Purchase | 2023-02-28 | 13G | United Therapeutics Corporation UTHR | BlackRock Inc. BLK | 4,726,986 10.200% | 216,775 (+4.81%) | Filing |
| 2023-01-24 1:56 pm Purchase | 2022-12-31 | 13G | United Therapeutics Corporation UTHR | BlackRock Inc. BLK | 4,510,211 9.900% | 271,036 (+6.39%) | Filing |
| 2022-02-02 7:11 pm Sale | 2021-12-31 | 13G | United Therapeutics Corporation UTHR | BlackRock Inc. BLK | 4,239,175 9.400% | -33,949 (-0.79%) | Filing |
| 2021-02-01 08:23 am Sale | 2020-12-31 | 13G | United Therapeutics Corporation UTHR | BlackRock Inc. BLK | 4,273,124 9.600% | -367,961 (-7.93%) | Filing |